3,7,7-Trimethylbicyclo[4.1.0]hept-3-ene

Catalog No. :
ACAQWE639
CAS No. :
13466-78-9
Molecular Formula :
C10H16
Molecular Weight :
136.24

IUPAC Name:3,7,7-trimethylbicyclo[4.1.0]hept-3-ene

3,7,7-Trimethylbicyclo[4.1.0]hept-3-ene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3,7,7-Trimethylbicyclo[4.1.0]hept-3-ene
IUPAC Name3,7,7-trimethylbicyclo[4.1.0]hept-3-ene
MDL No.MFCD00001315
Molecular FormulaC10H16
Molecular Weight136.24
SMILESCC1(C)C2CC=C(C)CC21
InChI KeyBQOFWKZOCNGFEC-UHFFFAOYSA-N
Synonym(+/-)-3-CARENE | HY-N6663 | 3-Carene, >=90% | (1S)-(+)-3-Carene | EN300-173315 | 3-Carene | 4,7,7-trimethylbicyclo[4.1.0]hept-3-ene | UNII-H2M15SNR6N | CAS-13466-78-9 | E77192 | EINECS 236-719-3 | Bicyclo[4.1.0]hept-3-ene, 3,7,7-trimethyl- | Delta-3-Caren
CAS No.13466-78-9

Safety Data

Pictogram
Health hazardFlammableHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H225-H304-H315-H317-H412
Precautionary Statement(s)
P210-P233-P240-P241-P242-P243-P261-P264-P272-P273-P280-P301+P310-P303+P361+P353-P331-P333+P313-P362-P370+P378-P403+P235-P405-P501

Synthetic Route by SureRoute

1. ACAQWE639 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMCAP915 route compound structure diagram
    ACMCAP9151071-36-9 In Stock
  4. Then
  5. ACAQWE639 route product structure diagram
    ACAQWE63913466-78-9
Inquiry

2. ACAQWE639 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACAQWE639 route product structure diagram
    ACAQWE63913466-78-9
Inquiry

Comments (0)